SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs > Momenta Pharmaceuticals, Inc. (MNTA)

MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
floblu14 Member Profile
Member Level 
Followed By 17
Posts 2,676
Boards Moderated 0
Alias Born 07/20/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2017 2:52:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2017 2:50:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/23/2017 2:48:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2017 2:15:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2017 2:15:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2017 2:14:39 PM
UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences "GlobeNewswire Inc." - 5/10/2017 4:05:00 PM
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences "GlobeNewswire Inc." - 5/10/2017 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/5/2017 4:49:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/2/2017 8:14:18 AM
Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results "GlobeNewswire Inc." - 5/2/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/1/2017 12:01:59 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/27/2017 8:15:45 AM
Momenta Pharmaceuticals to Webcast Presentation at the Deutsche Bank 42nd Annual Health Care Conference "GlobeNewswire Inc." - 4/26/2017 8:00:00 AM
Momenta Pharmaceuticals Announces Date of First Quarter 2017 Financial Results Conference Call and Webcast "GlobeNewswire Inc." - 4/18/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/17/2017 4:06:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/8/2017 7:52:54 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 3/3/2017 11:19:29 AM
Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference "GlobeNewswire Inc." - 2/28/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/24/2017 6:36:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/24/2017 6:25:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/24/2017 6:20:35 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 2/24/2017 4:56:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/21/2017 7:07:45 AM
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results "GlobeNewswire Inc." - 2/21/2017 7:00:00 AM
floblu14 Member Level  Wednesday, 12/07/11 09:36:20 AM
Re: None
Post # of 17264 
MOMENTA PHARMACEUTICALS, INC. v. AMPHASTAR PHARMACEUTICALS, INC.

MOMENTA PHARMACEUTICALS, INC., Plaintiff-Appellee, and
SANDOZ, INC., Plaintiff-Appellee,
v.
AMPHASTAR PHARMACEUTICALS, INC., INTERNATIONAL MEDICATION SYSTEMS, LTD., WATSON PHARMACEUTICALS, INC. and WATSON PHARMA, INC., Defendants-Appellants.

Nos. 2012-1062, 2012-xxxx, 2012-xxxx

United States Court of Appeals, Federal Circuit.


December 6, 2011.


This order is nonprecedential

ORDER

Upon consideration of the November 17, 2011 order expediting briefing on the merits of this appeal, the motions to consolidate this appeal with forthcoming appeals, the motion for leave to file a corrected opening brief, the motion for leave to file public and confidential versions of its reply in support of its motion to stay the injunction, and the motions to amend the official caption to add Watson Pharma, Inc.,

IT IS ORDERED THAT:
(1) Oral argument for the merits of the appeal is scheduled to be held at 10 a.m., January 24, 2012, in Courtroom 201. The parties shall notify the clerk in writing of the name of the counsel who will present oral argument no later than January 9, 2012.
(2) The motions to consolidate will be granted and the official caption will be amended to add the appeal numbers from the district court's November 23, 2011 order denying their motion to dissolve the injunction and the district court's December 2, 2011 order denying their emergency motion for relief from the injunction, when those new appeals are docketed by this court.
(3) The motions to reform the caption are granted. Watson Pharma, Inc. is added to the caption. The revised official caption is reflected above.

http://www.leagle.com/xmlResult.aspx?xmldoc=In%20FCO%2020111206163.xml&docbase=CSLWAR3-2007-CURR



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist